Molecular cloning and expression of novel fibroblast growth factor-2 conjugated with immunodominant domains of pseudomonas exotoxin

Haghighatfard H., Samaei N. M., Farazmandfar T., Hakemi M., Yamchi A., Jadidi-Niaragh F., ...More

Biomedical and Pharmacology Journal, vol.8, no.2, pp.1195-1200, 2015 (Scopus) identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.13005/bpj/876
  • Journal Name: Biomedical and Pharmacology Journal
  • Journal Indexes: Scopus
  • Page Numbers: pp.1195-1200
  • Keywords: Basic fibroblast growth factor (bFGF), Cloning, Pseudomonas exotoxin (PE)
  • Istanbul Medipol University Affiliated: No


Angiogenesis is very important in cancer growth and metastasis. Basic fibroblast growth factor (bFGF) as one of the most important angiogenesis factors is an attractive target for cancer vaccine. Due to low immunogenicity, it cannot stimulate an effective immune response. Theoretically, pseudomonas exotoxin (PE) as a potent immunogenic carrier protein when fused to low immunogenic antigens such as bFGF significantly increased immunogenicity of it. In this study, we tried to molecular cloning and expression of bFGF conjugated with immunodominant domains of pseudomonas exotoxin. The coding sequence of fusion protein composed of bFGF linked to PE domains 1b and 2 using EAAAK poly linker. The KDEL sequence was also used in C-terminal coding sequence. It was synthesized and expressed using recombinant DNA technology in the bacterial expression system. Expression of recombinant protein verified using SDS-PAGE and western blot analyses. Finally, it purified using Ni-affinity chromatography. The band close to 37 kDa in SDS-PAGE and western blot analyses was aligned completely to designed sequence. Purified recombinant protein also showed as a clear single band near to 37 kDa.